CONTACT
CATALOG PRODUCT FINDER
SEARCH BY KEYWORD:
SEARCH BY SCIENTIFIC FIELD:
Code
Product Name
Price
Buy
SP-Ab-12_0.1
A21G-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (natural variant)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (natural variant)
SP-Ab-12_0.5
A21G-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (natural variant)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (natural variant)
SP-Ab-28_0.1
A2T-Beta-Amyloid (1-40); HFIP treated (0.1mg)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Threonine (Thr)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Threonine (Thr)
SP-Ab-28_0.5
A2T-Beta-Amyloid (1-40); HFIP treated (0.5mg)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Threonine (Thr)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Threonine (Thr)
SP-Ab-25_0.1
A2T-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Threonine (Thr)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Threonine (Thr)
SP-Ab-25_0.5
A2T-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Threonine (Thr)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Threonine (Thr)
SP-Ab-27_0.1
A2V-Beta-Amyloid (1-40); HFIP treated (0.1mg)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Valine (Val)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Valine (Val)
SP-Ab-27_0.5
A2V-Beta-Amyloid (1-40); HFIP treated (0.5mg)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Valine (Val)
Variant of human A beta (Amyloid beta) protein, where Ala 2 is replaced by a Valine (Val)
SP-Ab-26_0.1
A2V-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Valine (Val)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Valine (Val)
SP-Ab-26_0.5
A2V-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Valine (Val)
Variant of human Amyloid beta A4 protein, where Ala 2 is replaced by a Valine (Val)
SP-Ab-20_0.1
Beta-Amyloid (1-37); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-20_0.5
Beta-Amyloid (1-37); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-21_0.1
Beta-Amyloid (1-38); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-21_0.5
Beta-Amyloid (1-38); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-32-0.1
Beta-Amyloid (1-40) Scrambled; HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
SP-Ab-32-0.5
Beta-Amyloid (1-40) Scrambled; HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
SP-Ab-18_0.1
Beta-Amyloid (1-40)-Lys(Biotinoyl); HFIP (0.1mg)
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-18_0.5
Beta-Amyloid (1-40)-Lys(Biotinoyl); HFIP (0.5mg)
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-06_0.1
Beta-Amyloid (1-40); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-06_0.5
Beta-Amyloid (1-40); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-31-0.1
Beta-Amyloid (1-42) Scrambled; HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
SP-Ab-31-0.5
Beta-Amyloid (1-42) Scrambled; HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein, sequence scrambled
SP-Ab-16_0.1
Beta-Amyloid (1-42)-Lys(Biotinoyl); HFIP treated (0.1mg)
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-16_0.5
Beta-Amyloid (1-42)-Lys(Biotinoyl); HFIP treated (0.5mg)
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic C-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-07_0.1
Beta-Amyloid (1-42); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-07_0.5
Beta-Amyloid (1-42); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-08_0.1
Beta-Amyloid (1-43); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-08_0.5
Beta-Amyloid (1-43); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-22_0.1
Beta-Amyloid (17-40); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-23_0.5
Beta-Amyloid (17-42); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-19_0.1
Biotinoyl-Beta-Amyloid (1-40); HFIP treated (0.1mg)
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-19_0.5
Biotinoyl-Beta-Amyloid (1-40); HFIP treated (0.5mg)
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-17_0.1
Biotinoyl-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-17_0.5
Biotinoyl-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
Synthetic N-terminally biotinylated peptide derived from the N-terminal region of human Amyloid beta A4 protein
SP-Ab-15_0.1
D23N-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Iowa variant of human Amyloid beta A4 protein, where Asp 23 is replaced by an Asparagine (Asn)
Iowa variant of human Amyloid beta A4 protein, where Asp 23 is replaced by an Asparagine (Asn)
SP-Ab-15_0.5
D23N-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Iowa variant of human Amyloid beta A4 protein, where Asp 23 is replaced by an Asparagine (Asn)
Iowa variant of human Amyloid beta A4 protein, where Asp 23 is replaced by an Asparagine (Asn)
SP-Ab-09_0.1
D7N-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Tottori-Japanese variant of human Amyloid beta A4 protein, where Asp 7 is replaced by an Asparagine (Asn)
Tottori-Japanese variant of human Amyloid beta A4 protein, where Asp 7 is replaced by an Asparagine (Asn)
SP-Ab-09_0.5
D7N-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Tottori-Japanese variant of human Amyloid beta A4 protein, where Asp 7 is replaced by an Asparagine (Asn)
Tottori-Japanese variant of human Amyloid beta A4 protein, where Asp 7 is replaced by an Asparagine (Asn)
SP-Ab-10_0.1
E11K-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Variant of human Amyloid beta A4 protein, where Glu 11 is replaced by a Lysine (Lys)
Variant of human Amyloid beta A4 protein, where Glu 11 is replaced by a Lysine (Lys)
SP-Ab-10_0.5
E11K-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Variant of human Amyloid beta A4 protein, where Glu 11 is replaced by a Lysine (Lys)
Variant of human Amyloid beta A4 protein, where Glu 11 is replaced by a Lysine (Lys)
SP-Ab-11_0.1
E22G-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Arctic variant of human Amyloid beta A4 protein, where Glu 22 is replaced by a Glycine (Gly)
Arctic variant of human Amyloid beta A4 protein, where Glu 22 is replaced by a Glycine (Gly)
SP-Ab-11_0.5
E22G-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Arctic variant of human Amyloid beta A4 protein, where Glu 22 is replaced by a Glycine (Gly)
Arctic variant of human Amyloid beta A4 protein, where Glu 22 is replaced by a Glycine (Gly)
SP-Ab-13_0.1
E22K-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Italian variant of human Amyloid beta A4 protein, where Glu 22 is replaced by a Lysine (Lys)
Italian variant of human Amyloid beta A4 protein, where Glu 22 is replaced by a Lysine (Lys)
SP-Ab-13_0.5
E22K-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Italian variant of human Amyloid beta A4 protein, where Glu 22 is replaced by a Lysine (Lys)
Italian variant of human Amyloid beta A4 protein, where Glu 22 is replaced by a Lysine (Lys)
SP-Ab-14_0.1
E22Q-Beta-Amyloid (1-42); HFIP treated (0.1mg)
Dutch variant of human Amyloid beta A4 protein, where Glu 22 is replaced by a Glutamine (Gln)
Dutch variant of human Amyloid beta A4 protein, where Glu 22 is replaced by a Glutamine (Gln)
SP-Ab-14_0.5
E22Q-Beta-Amyloid (1-42); HFIP treated (0.5mg)
Dutch variant of human Amyloid beta A4 protein, where Glu 22 is replaced by a Glutamine (Gln)
Dutch variant of human Amyloid beta A4 protein, where Glu 22 is replaced by a Glutamine (Gln)
SP-Ab-24_0.1
S26C-Beta-Amyloid (1-40) Dimer; HFIP treated (0.1mg)
Homodimer of human Amyloid beta A4 peptide (1-40), where Ser 26 is replaced by an Cysteine (Cys) that is used for dimerization
Homodimer of human Amyloid beta A4 peptide (1-40), where Ser 26 is replaced by an Cysteine (Cys) that is used for dimerization
SP-Ab-24_0.5
S26C-Beta-Amyloid (1-40) Dimer; HFIP treated (0.5mg)
Homodimer of human Amyloid beta A4 peptide (1-40), where Ser 26 is replaced by an Cysteine (Cys) that is used for dimerization
Homodimer of human Amyloid beta A4 peptide (1-40), where Ser 26 is replaced by an Cysteine (Cys) that is used for dimerization
SPT-CYT-POOL-L-hum
SpikeMix™ Cytokines (Human) - heavy
Pool of 461 heavy isotope labeled proteotypic peptides for 361 human cytokines (e.g. interleukines, intereferons, lymphokines). Stable isotope labeled peptide mixture for relat...
Pool of 461 heavy isotope labeled proteotypic peptides for 361 human cytokines (e.g. interleukines, intereferons, lymphokines). Stable isotope labeled peptide mixture for relat...
SPT-CYT-L-hum
SpikeTides™ Set Cytokines (Human) - heavy
Collection of 461 heavy labeled proteotypic peptides for 219 human cytokines (e.g. interleukines, intereferons, lymphokines). Stable isotope labeled for usage in mass-spectrome...
Collection of 461 heavy labeled proteotypic peptides for 219 human cytokines (e.g. interleukines, intereferons, lymphokines). Stable isotope labeled for usage in mass-spectrome...
SP-Ab-29_0.1
pyrGlu Beta-Amyloid (3-40); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (variant)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (variant)
SP-Ab-29_0.5
pyrGlu Beta-Amyloid (3-40); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (variant)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (variant)
SP-Ab-30_0.1
pyrGlu³ Beta-Amyloid (3-42); HFIP treated (0.1mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (variant) for Alzheimer research
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (variant) for Alzheimer research
SP-Ab-30_0.5
pyrGlu³ Beta-Amyloid (3-42); HFIP treated (0.5mg)
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (variant) for Alzheimer research
Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (variant) for Alzheimer research
Loading. Please wait
News
NEW: SARS-COV-2 B.1.1.7(UK) & HCoV NCAP PepMixesTM
(Jan 2021)
Read more
13 NEW Immunopeptidomics Kits
References for MHC I binding HLA peptides to increase accuracy of neo-epitope identification
(Dec 2020)
Read more
Infectious diseases beyond COVID-19
JPT's peptide formats in the literature
(Oct 2020)
Read more
SARS COV-2 Mass Spec Reference Kit Released!:
SARS-CoV-2 SpikeMix for Mass Spectrometry covers spike, NCAP, VME-1 & ORF9B
(July 2020)
Read more
Quality Assurance
All production is performed according to ISO 9001:2015 standards.
